Velasco LMC, Chávez OJL

Language: Spanish
References: 29
Page: 45-51
PDF size: 82.10 Kb.

ABSTRACT

Thromboangiitis obliterans (TAO) is few frequent in our environment, with occlusive arterial that occurs mainly in the small and medium-sized vessels, of unknown cause with humoral and immunological factors that affect peripheral microcirculation. One case is presented who finished with bilateral amputation of the lower limbs, with heavy smoking and physical, mental and family repercutions, without getting work installation. Bibliography was reviewed, it’s underline the importance of smoking in the disease onset and its maintenance, its epidemiology, its diagnosis criteria, complementary studies, proposed treatments and its natural evolution. The final outcome of present case was failed. Iloprost is a available drug only in Europe. Transference surgery of omentus, sympathectomy and spinal cord stimulation had not been effectives. Amputation of lower limbs is a final resource for saving patient’s life.

REFERENCES

1. Adar R, Papa MZ, Halpern Z et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983; 308(19): 1113-6.

2. Grove WJ, Stansby GP. Buerger’s disease and cigarette smoking in Bangladesh. Ann R Coll Surg Engl 1992; 74(2): 115-7; discussion 118.

3. Eichhorn J, Sima D, Lindschau C et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998; 315(1): 17-23.

4. Deitch EA, Sikkema WW. Intestinal manifestation of Buerger’s disease: case report and literature review. Am Surg 1981; 47(7): 326-8.

5. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet 1990; 335(8689): 555-7.

6. Hussein EA, el Dorri A. Intra-arterial streptokinase as adjuvant therapy for complicated Buerger’s disease: early trials. Int Surg 1993; 78(1): 54-8.

7. Iwai T. Buerger’s disease with intestinal involvement. Int J Cardiol 1998; 66(Suppl 1): S257-63; discussion S265.

8. Isner JM, Baumgartner I, Rauh G et al: Treatment of thromboangiitis obliterans (Buerger’s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998; 28(6): 964-73; discussion 73-5.

9. Joce JW. Buerger’s disease (thromboangiitis obliterans). Rheum Dis Clin North Am 1990; 16(2): 463-70.

10. Kubota Y, Kichikawa K, Uchida H, Nishimine K, Hirohashi R, Ohishi H. Superselective urokinase infusion therapy for dorsalis pedis artery occlusion in Buerger’s disease. Cardiovasc Intervent Radiol 1997; 20(5): 380-2.

11. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger’s disease). Acta Pathol Jpn 1989; 39(3): 153-8.

12. Lie JT. Visceral intestinal Buerger’s disease. Int J Cardiol 1998; 66(Suppl 1): S249-56.

13. Lambeth JT, Yong NK. Arteriographic findings in thromboangiitis obliterans with emphasis on femoropopliteal involvement. Am J Roentgenol Radium Ther Nucl Med 1970; 109(3): 553-62.

14. Makita S, Nakamura M, Murakami H et al. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger’s disease). Circulation 1996; 94(9 Suppl): II211-5.

15. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger’s disease in Japan. Surgery 1998; 124(3): 498-502.

16. Olin JW, Young JR, Graor RA et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation 1990; 82(5 Suppl): IV3-8.

17. Sasajima T, Kubo Y, Inaba M et al. Role of infrainguinal bypass in Buerger’s disease: an eighteen-year experience. Eur J Vasc Endovasc Surg 1997; 13(2): 186-92.

18. Sayin A, Bozkurt AK, Tuzun H et al. Surgical treatment of Buerger’s disease: experience with 216 patients. Cardiovasc Surg 1993; 1(4): 377-80.

19. Singh I, Ramteke VK. The role of omental transfer in Buerger’s disease: New Delhi’s experience. Aust N Z J Surg 1996; 66(6): 372-6.

20. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger’s disease). J Vasc Surg 1999; 29(5): 928-35.

21. The European TAO Study Group: Oral iloprost in the treatment of thromboangiitis obliterans (Buerger’s disease): a double-blind, randomized, placebo-controlled trial. Eur J Vasc Endovasc Surg 1998; 15(4): 300-7.

22. Lau H, Cheng SW. Buerger’s disease in Hong Kong: a review of 89 cases. Aust N Z J Surg 1997; 67(5): 264-9.

23. Yorukoglu Y, Ilgit E, Zengin M, Nazliel K, Salman E, Yucel E. Thromboangiitis obliterans (Buerger’s disease) in women (a reevaluation). Angiology 1993; 44(7): 527-32.

24. Watarida S, Shiraishi S, Fujimura M, Hirano M, Nishi T, Imura M, Yamamoto I. Laparoscopic lumbar sympathectomy for lower-limb disease. Surg Endosc 2002; 16(3): 500-3.

25. Alpaslan M, Akgun G, Doven O, Oral D. Thrombus in the main pulmonary artery of a patient with thromboangiitis obliterans: observation by transthoracic echocardiography. Eur J Echocardiogr 2001; 2(2): 139-40.

26. Talwar S, Choudhary SK. Omentopexy for limb salvage in Buerger’s disease: indications, technique and results. J Postgrad Med 2001; 47(2): 137-42.

27. Leavitt RY, Bressler P, Fauci AS. Buerger’s disease in a young woman. Am J Med 1986; 80(5): 1003-5.

28. Chierichetti F, Mambrini S, Bagliani A, Odero A. Treatment of Buerger’s disease with electrical spinal cord stimulation-review of three cases. Angiology 2002; 53(3): 341-7.

29. Sasaki S, Sakuma M, Kunihara T, Yasuda K. Distribution of arterial involvement in thromboangiitis obliterans (Buerger’s disease): results of a study conducted by the Intractable Vasculitis Syndromes Research Group in Japan. Surg Today 2000; 30(7): 600-5.